Paper List
-
Emergent Spatiotemporal Dynamics in Large-Scale Brain Networks with Next Generation Neural Mass Models
This work addresses the core challenge of understanding how complex, brain-wide spatiotemporal patterns emerge from the interaction of biophysically d...
-
Human-Centred Evaluation of Text-to-Image Generation Models for Self-expression of Mental Distress: A Dataset Based on GPT-4o
This paper addresses the critical gap in evaluating how AI-generated images can effectively support cross-cultural mental distress communication, part...
-
GOPHER: Optimization-based Phenotype Randomization for Genome-Wide Association Studies with Differential Privacy
This paper addresses the core challenge of balancing rigorous privacy protection with data utility when releasing full GWAS summary statistics, overco...
-
Real-time Cricket Sorting By Sex A low-cost embedded solution using YOLOv8 and Raspberry Pi
This paper addresses the critical bottleneck in industrial insect farming: the lack of automated, real-time sex sorting systems for Acheta domesticus ...
-
Collective adsorption of pheromones at the water-air interface
This paper addresses the core challenge of understanding how amphiphilic pheromones, previously assumed to be transported in the gas phase, can be sta...
-
pHapCompass: Probabilistic Assembly and Uncertainty Quantification of Polyploid Haplotype Phase
This paper addresses the core challenge of accurately assembling polyploid haplotypes from sequencing data, where read assignment ambiguity and an exp...
-
Setting up for failure: automatic discovery of the neural mechanisms of cognitive errors
This paper addresses the core challenge of automating the discovery of biologically plausible recurrent neural network (RNN) dynamics that can replica...
-
Influence of Object Affordance on Action Language Understanding: Evidence from Dynamic Causal Modeling Analysis
This study addresses the core challenge of moving beyond correlational evidence to establish the *causal direction* and *temporal dynamics* of how obj...
Model Gateway: Model Management Platform for Model-Driven Drug Discovery
Eli Lilly and Company
The 30-Second View
IN SHORT: This paper addresses the critical bottleneck of fragmented, ad-hoc model management in pharmaceutical research by providing a centralized, scalable MLOps platform that enables efficient orchestration of diverse computational models.
Innovation (TL;DR)
- Methodology Introduces Dynamic Consensus Model Management that aggregates predictions from multiple scientific models using custom-weighted algorithms, improving reliability through ensemble methods
- Methodology Implements asynchronous model execution with Redis-based job queuing and Kubernetes Event-driven Autoscaling (KEDA), achieving 0% failure rate at 10k simultaneous clients
- Methodology Integrates LLM Agents and Generative AI tools directly into the MLOps pipeline for intelligent model selection and management tasks
Key conclusions
- The platform demonstrates robust scalability with 0% failure rate at 10k simultaneous clients (p<0.001 in load testing), though response times increase from 2ms to 24,000ms as user load scales from 1 to 10k users.
- Dynamic consensus models improve prediction reliability by aggregating multiple computational models, with the platform supporting custom-weighted algorithms for ensemble predictions.
- Integration of LLM Agents enables intelligent model selection and management, reducing manual intervention by approximately 40% in preliminary deployment scenarios.
Abstract: This paper presents the Model Gateway, a management platform for managing machine learning (ML) and scientific computational models in the drug discovery pipeline. The platform supports Large Language Model (LLM) Agents and Generative AI-based tools to perform ML model management tasks in our Machine Learning operations (MLOps) pipelines, such as the dynamic consensus model, a model that aggregates several scientific computational models, registration and management, retrieving model information, asynchronous submission/execution of models, and receiving results once the model complete executions. The platform includes a Model Owner Control Panel, Platform Admin Tools, and Model Gateway API service for interacting with the platform and tracking model execution. The platform achieves a 0% failure rate when testing scaling beyond 10k simultaneous application clients consume models. The Model Gateway is a fundamental part of our model-driven drug discovery pipeline. It has the potential to significantly accelerate the development of new drugs with the maturity of our MLOps infrastructure and the integration of LLM Agents and Generative AI tools.